EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PAK1‐mediated HDAC1 phosphorylation promotes prostatic stromal fibrosis through SP1‐dependent TGF‐β1 transcription in benign prostatic hyperplasia

Liang Zhou, Jiaren Li, Youyou Li, Yichuan Wang, Jiahao Liu, Cheng Li, Hui Xie, Long Wang

VIEW · 16.11.2026

DOI: 10.1002/viw2.70226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift VIEW, online erschienen am 16.11.2026. Verfasst von Liang Zhou und 7 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostatic fibrosis is an important contributor to the progression and clinical manifestations of benign prostatic hyperplasia (BPH), whereas the underlying molecular mechanisms remain incompletely understood. In this study, integrative multi‐omics analyses, including RNA sequencing, proteomics, and phosphoproteomics, identified p21‐activated kinase 1 (PAK1) as a key regulator associated with prostatic fibrosis. PAK1 expression was markedly increased and was closely associated with the progression of prostatic fibrosis and BPH. Transcriptomic analyses further indicated that the profibrotic effects of PAK1 were closely related to activation of the TGF‐β signaling pathway. Functional experiments demonstrated that PAK1 promoted fibrosis‐related phenotypes and enhanced TGF‐β1 expression. Mechanistically, PAK1‐induced phosphorylation of histone deacetylase 1 (HDAC1) was associated with reduced SP1 acetylation and enhanced SP1‐dependent transcriptional activity, thereby facilitating TGF‐β1 transcription. In vivo, both genetic silencing of PAK1 and pharmacological inhibition with IPA‐3 alleviated prostatic fibrosis and attenuated BPH‐associated pathological changes. Collectively, these findings support a model in which PAK1 contributes to prostatic fibrosis and BPH progression through modulation of the HDAC1/SP1/TGF‐β1 signaling axis and suggest that PAK1 may represent a potential therapeutic target for BPH.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhou, L., Li, J., Li, Y., Wang, Y., Liu, J., Li, C., Xie, H., & Wang, L. (2026). PAK1‐mediated HDAC1 phosphorylation promotes prostatic stromal fibrosis through SP1‐dependent TGF‐β1 transcription in benign prostatic hyperplasia. VIEW. https://doi.org/10.1002/viw2.70226

Vancouver

Zhou L, Li J, Li Y, Wang Y, Liu J, Li C, et al. PAK1‐mediated HDAC1 phosphorylation promotes prostatic stromal fibrosis through SP1‐dependent TGF‐β1 transcription in benign prostatic hyperplasia. VIEW. 2026. doi:10.1002/viw2.70226

BibTeX
@article{Zhou2026,
  author = {Zhou, Liang and Li, Jiaren and Li, Youyou and Wang, Yichuan and Liu, Jiahao and Li, Cheng and Xie, Hui and Wang, Long},
  title = {PAK1‐mediated HDAC1 phosphorylation promotes prostatic stromal fibrosis through SP1‐dependent TGF‐β1 transcription in benign prostatic hyperplasia},
  journal = {VIEW},
  year = {2026},
  doi = {10.1002/viw2.70226}
}
Kostenlos starten →